NASDAQ$SBRA

Sabra Health Care REIT Inc · Q4 2023 earnings

Q4 2023 earnings · · Investor relations

Briefing

Sabra Health Care REIT reported Q4 2023 results, showing net income of $0.07 per diluted common share, FFO of $0.30, Normalized FFO of $0.32, and AFFO of $0.32.

Sabra Health Care REIT announced its Q4 2023 results, with key highlights including a net income of $0.07 per diluted common share, FFO of $0.30, Normalized FFO of $0.32, and AFFO of $0.32. The company expanded its relationship with Ignite Medical Resorts through the acquisition of two skilled nursing facilities. Sabra also introduced 2024 earnings guidance and declared a quarterly cash dividend of $0.30 per share of common stock.

  • Net Income was $0.07 per diluted common share.
  • FFO was $0.30 per diluted common share.
  • Normalized FFO was $0.32 per diluted common share.
  • AFFO was $0.32 per diluted common share.

Headline financials

Total Revenue

$164M

Previous: $165M-0.4%
EPS (adj)

$0.32

Previous: $0.37-13.5%
FFO per diluted common share

$0.30

Previous: $0.25+20.0%
Normalized FFO per share

$0.32

Previous: $0.37-13.5%
AFFO per diluted common share

$0.32

Previous: $0.34-5.9%
Normalized AFFO per share

$0.33

Previous: $0.37-10.8%
Capital Expenditures

$0.00

No prior period
Net Income

$17.2M

Previous: -$84.9M+120.2%
Operating Income

$19.1M

Previous: $3.49M+447.2%
Gross Profit

$71.6M

Previous: $121M-40.9%
Stock-Based Comp

$2.45M

Previous: $2.09M+17.4%

Revenue & EPS history

Sabra Health Care REIT · Revenue · Quarterly

$164M

Q4 2023-0.4%vs Q4 2022
Beat estimate in 11 of 15 quarters(73%)
ActualEstimate

Revenue by segment

Sabra Health Care REIT · $162M total across 3 segments · Q3 2023

  • Rental and related revenues
    $93.1M+10.5%
  • Resident fees and services
    $59.7M+25.5%
  • Interest and other income
    $8.79M-1.6%

Forward guidance

Sabra introduced 2024 earnings guidance ranges as follows (attributable to common stockholders, per diluted common share): Net Income: $0.53 - $0.57, FFO: $1.33 - $1.37, Normalized FFO: $1.34 - $1.38, AFFO: $1.38 - $1.42, Normalized AFFO: $1.39 - $1.43. Earnings guidance above assumes no 2024 acquisition or disposition activity.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2023

Historical avgQ4 2023

-0.5%

Avg return

Earnings day

-0.2%

Avg return

5 days after

-0.4%

Avg return

30 days after

45%

27 / 60 earnings

Positive

+10.4%

Q1 2022

Best reaction

-13.1%

Q3 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-0.5%+0.1%-2.3%
Q3 2025+2.3%+4.2%+11.7%
Q1 2025+1.2%+0.1%-0.2%
Q4 2024-1.0%-0.8%+4.3%
Q3 2024-4.8%-4.1%-4.3%
Q2 2024-0.1%-1.1%+4.7%
Q1 2024-1.7%-1.7%-5.1%
Q4 2023+0.4%+0.4%+6.0%
Q3 2023+0.7%+2.0%+1.6%
Q2 2023+0.8%-0.9%-1.2%
Q1 2023-0.5%+1.7%+1.7%
Q4 2022-4.2%-6.3%-22.0%
Q3 2022-13.1%-3.5%-7.1%
Q2 2022+0.0%+2.9%-4.0%
Q1 2022+10.4%+6.0%+10.4%
Q4 2021-3.9%-0.7%+5.6%
Q3 2021-2.1%-0.1%-11.2%
Q2 2021-3.7%-4.7%-8.7%
Q1 2021-2.2%+0.0%-1.3%
Q4 2020+1.7%-3.6%-0.8%
Q3 2020-4.0%+15.7%+27.6%
Q2 2020+4.4%+7.7%+5.9%
Q1 2020-5.7%-1.6%+35.6%
Q4 2019-3.5%-11.1%-50.1%
Q3 2019+3.3%+0.6%-6.4%
Q2 2019+5.5%+4.5%+8.5%
Q1 2019-1.6%+0.5%-0.5%
Q4 2018-2.7%-9.6%-2.0%
Q3 2018-0.6%-1.4%-12.9%
Q2 2018-0.3%-0.3%+3.4%
Q1 2018+3.3%+2.9%+7.6%
Q4 2017+2.8%+4.8%+0.2%
Q3 2017-1.5%-2.7%-2.7%
Q2 2017+1.6%+0.9%-4.1%
Q1 2017-10.2%-8.8%-14.2%
Q4 2016+0.6%+5.4%+6.7%
Q3 2016-8.9%-7.2%-0.4%
Q2 2016+1.6%+2.4%+6.6%
Q1 2016+4.4%
Q4 2015+8.3%
Q3 2015-2.9%
Q2 2015-4.6%
Q1 2015-6.0%
Q4 2014-0.9%
Q3 2014-0.9%
Q2 2014-2.0%
Q1 2014-2.6%
Q4 2013+0.8%
Q3 2013+4.1%
Q2 2013-7.3%
Q1 2013+2.4%
Q4 2012+0.0%
Q3 2012+2.6%
Q2 2012+3.0%
Q1 2011-4.6%
Q1 2012+2.4%
Q4 2011+5.1%
Q3 2011+7.5%
Q2 2011+3.9%
Q4 2010-6.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro